表紙
市場調查報告書
商品編碼
1069628

DNA奈米技術的全球市場:各類型,各用途,各終端用戶,各地區,競爭預測和機會,2017年∼2027年

Global DNA Nanotechnology Market, By Type, By Application, By End User, By Region, Competition Forecast and Opportunities, 2017-2027

出版日期: | 出版商: TechSci Research | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球DNA奈米技術的市場規模,在預測期間的2023年∼2027年預計顯著擴大。

該市場的成長背景,是奈米技術的進步高漲,和在醫療保健領域的用途擴大。製藥企業對有效且有效率的藥物遞輸系統的需求劇增,和市場參與企業對奈米粒子的高額投資,成為該市場今後的促進成長因素。

本報告提供全球DNA奈米技術市場相關調查,市場概要,以及各類型,各用途,各終端用戶,各地區的趨勢,競爭趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 COVID-19對全球DNA奈米技術市場的影響

第5章 客戶的迴響

第6章 全球DNA奈米技術市場預測

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型(結構的DNA奈米技術,動態DNA奈米技術)
    • 各用途(標靶藥物傳輸,智慧藥丸,奈米微影術,其他)
    • 各終端用戶(生物科技企業、製藥公司,學術、研究機關,其他)
    • 各企業(2021年)
    • 各地區
  • 市場地圖

第7章 北美的DNA奈米技術市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 北美:各國分析

第8章 歐洲的DNA奈米技術市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 歐洲:各國分析

第9章 亞太地區的DNA奈米技術市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 亞太地區:各國分析

第10章 南美的DNA奈米技術市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 南美:各國分析

第11章 中東、非洲的DNA奈米技術市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 中東、非洲:各國分析

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • NuProbe USA Inc.
  • tilibit nanosystems GmbH
  • GATTAquant GmbH
  • Genisphere LLC
  • Inovio Pharmaceuticals, Inc.
  • Novartis International AG

第15章 策略性推薦事項

目錄
Product Code: 8174

Global DNA nanotechnology market is projected to register growth at a significant rate during the forecast period, 2023-2027. The market growth can be attributed to the rising advancements in nanotechnology and its growing number of applications in the healthcare sector. A surge in demand for the effective and efficient drug delivery system in pharmaceutical companies and heavy investments from market players in nano particles are driving the demand for the future growth of the global DNA nanotechnology market. Nanotechnology is the branch of science and engineering that deals with designing, producing, and utilizing structures through manipulating atoms and molecules at nanoscale. Nanotechnology finds application in multiple domains of science such as organic chemistry, semiconductor physics, molecular biology, nanomedicine, nanoelectronics, etc. DNA nanotechnology can perform computation in a biocompatible format to synthesize smart drugs for targeted drug delivery. Hence, the technology is rapidly adopted by the pharmaceutical industry players, which is expected to fuel the growth of the global DNA nanotechnology market. Increasing investments from the government and private sector in the healthcare sector to support advancements in therapeutics, pharmaceutical products, medical devices, etc., are expected to drive the growth of the global DNA nanotechnology market. Furthermore, increasing incidences of chronic disorders such as cardiovascular problems, diabetes, genetic diseases, cancer, etc., are substantiating the growth of the global DNA nanotechnology market.

The global DNA nanotechnology market segmentation is based on type, application, end user, regional distribution, and competitive landscape. Based on application, the market is further divided into targeted drug delivery, smart pills, nanolithography, and others. Targeted drug delivery segment is anticipated to hold the largest share in the global DNA nanotechnology market in the coming years owing to factors such as rising demand for efficient and targeted drug delivery and growing instances of cancer across the world. However, smart pills are expected to grow at the fastest rate in the global DNA nanotechnology market owing to their rising usage for personalized medicine and nanomedicine.

Major players operating in the global DNA nanotechnology market are NuProbe USA Inc., tilibit nanosystems GmbH, GATTAquant GmbH, Genisphere LLC, Inovio Pharmaceuticals, Inc., Novartis International AG, etc.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2023-2027

Objective of the Study:

  • To analyze the historical growth in the market size of global DNA nanotechnology market from 2017 to 2021.
  • To estimate and forecast the market size of global DNA nanotechnology market from 2022 to 2027 and growth rate until 2027.
  • To classify and forecast global DNA nanotechnology market based on product type, application, fuel type, region, and competitive landscape.
  • To identify dominant region or segment in the global DNA nanotechnology market.
  • To identify drivers and challenges for global DNA nanotechnology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global DNA nanotechnology market.
  • To identify and analyze the profile of leading players operating in the global DNA nanotechnology market.
  • To identify key sustainable strategies adopted by market players in the global DNA nanotechnology market.

Report Scope:

In this report, global DNA nanotechnology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • DNA Nanotechnology Market, By Type:

Structural DNA Nanotechnology

  • Extended Lattices
  • Discrete Structures
  • Templated Assembly

Dynamic DNA Nanotechnology

  • Nanomechanical Devices
  • Strand Displacement Cascades
  • DNA Nanotechnology Market, By Application:

Targeted Drug Delivery

Smart Pills

Nanolithography

Others

  • DNA Nanotechnology Market, By End User:

Biotechnology & Pharmaceutical Companies

Academic & Research Institutions

Others

  • DNA Nanotechnology Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

South America

  • Brazil
  • Argentina
  • Colombia

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of the global DNA nanotechnology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • DNA nanotechnology service provider companies/partners
  • Suppliers/Distributers
  • End-Users
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to global DNA nanotechnology market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc. besides allowing them in strategizing investments and capitalizing on market opportunities.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global DNA nanotechnology market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global DNA Nanotechnology Market

5. Voice of Customer

  • 5.1. Factors Contributing to Switch Over to DNA Nanotechnology
  • 5.2. Barriers to Adoption of DNA Nanotechnology
  • 5.3. Brand Awareness

6. Global DNA Nanotechnology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 6.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 6.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 6.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 6.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 6.2.4. By Company (2021)
    • 6.2.5. By Region
  • 6.3. Market Map

7. North America DNA Nanotechnology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 7.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 7.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 7.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 7.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States DNA Nanotechnology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Mexico DNA Nanotechnology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Canada DNA Nanotechnology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe DNA Nanotechnology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 8.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 8.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 8.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 8.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France DNA Nanotechnology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany DNA Nanotechnology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom DNA Nanotechnology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy DNA Nanotechnology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain DNA Nanotechnology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific DNA Nanotechnology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 9.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 9.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 9.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 9.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China DNA Nanotechnology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India DNA Nanotechnology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Korea DNA Nanotechnology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. Japan DNA Nanotechnology Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia DNA Nanotechnology Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America DNA Nanotechnology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 10.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 10.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 10.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 10.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil DNA Nanotechnology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina DNA Nanotechnology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia DNA Nanotechnology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa DNA Nanotechnology Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)
      • 11.2.1.1. Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)
      • 11.2.1.2. Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)
    • 11.2.2. By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)
    • 11.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 11.2.4. By Country
  • 11.3. Middle east and Africa: Country Analysis
    • 11.3.1. South Africa DNA Nanotechnology Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia DNA Nanotechnology Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE DNA Nanotechnology Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User
    • 11.3.4. Egypt DNA Nanotechnology Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type
        • 11.3.4.2.2. By Application
        • 11.3.4.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends and Developments

14. Competitive Landscape

  • 14.1. NuProbe USA Inc.
  • 14.2. tilibit nanosystems GmbH
  • 14.3. GATTAquant GmbH
  • 14.4. Genisphere LLC
  • 14.5. Inovio Pharmaceuticals, Inc.
  • 14.6. Novartis International AG

15. Strategic Recommendations